Bks Advisors »

Takeda Pharmaceutical shares owned by Bks Advisors

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Bks Advisors from 13F filings

Historical chart of Bks Advisors investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Bks Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Bks Advisors

Quarter filed Position value Share count Share price at filing
2019-03-31 $428k 21k 20.39

More positions owned by Bks Advisors

Ark Etf Tr innovation etf (ARKK)
SPDR DJ Wilshire Small Cap Value (SLYV)
Apple (AAPL)
Technology SPDR (XLK)
Visa (V)
Servicenow (NOW)
Proshares Tr S&p 500 Aristo (NOBL)
Eli Lilly & Co. (LLY)
Consumer Discretionary SPDR (XLY)
iShares MSCI EAFE Index Fund (EFA)
Verizon Communications (VZ)
SPDR DJ Wilshire Large Cap (SPLG)
Amazon (AMZN)
First Trust Ind/Prod AlphaDEX (FXR)
Goldman Sachs Etf Tr (GSLC)

View all positions for Bks Advisors

Top funds holding Takeda Pharmaceutical

Millennium Management
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
Polygon Management
Managed Asset Portfolios
Van Eck Associates Corp.
Causeway Capital Management
Y.D. More Investments
Jane Street
Citadel Advisors
Bank of America Corporation
Wells Fargo & Company
Natixis Asset Management Advisors
Nomura Holdings

View all funds holding Takeda Pharmaceutical